Abstract
Reflecting the multifactorial background of gastroesophageal reflux disease (GERD) and the large variation in its clinical presentation, it is not surprising that “one therapeutic option would fit all patients with GERD” is not a realistic therapeutic option. Extracting data from literature regarding therapeutic decision-making requires a critical view for the composition of the involved patient populations and especially regarding indications for surgery. GERD may present with several different symptoms, which can overlap with other diseases and other disorders presenting with reflux-like symptoms. Therefore, the most important initial issue, when facing a patient, who needs a decision regarding an indication for endoscopic or surgical therapy, is a precise diagnostic workup including an upper GI-endoscopy, impedance-pH-monitoring, high-resolution manometry, and in cases of dysphagia or signs of delayed gastric emptying additional radiographic and scintigraphic investigations. PPI therapy is very effective and it remains the standard treatment for acute symptoms of GERD. There is no place for surgical therapy as an acute therapeutic option. In addition, it must be emphasized that PPI therapy is the most frequent form of long-term therapy in GERD patients and shows a good safety profile. The worst component in waiting for many years to establish a justified indication for antireflux surgery is the fact that after unnecessary waiting the chances for being able to correct effectively the anatomical and functional changes in such a patient are decreasing, if this decision is postponed too long. Therefore, it is important to start diagnostic activities at the right time to assess the functional and anatomic status of the patient and determine what the nature of her/his GERD is in order to gain objective findings for therapeutic decision-making. It is very important for every single patient to undergo adequate investigations prior to surgery. Optimal information about the background of the disease can only be obtained by extensive diagnostic testing of the individual situation of the disease and its pathophysiologic causes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeMeester TR. Etiology and natural history of gastroesophageal reflux disease and predictors of progressive disease. In: Yeo CJ, DeMeester SR, Mc Fadden DW, editors. Shackelford’s surgery of the alimentary tract. 8th ed. Philadelphia: Elsevier; 2019. p. 204–20.
Fuchs KH, Freys SM, Heimbucher J, Fein M, Thiede A. Pathophysiologic spectrum in patients with gastroesophageal reflux disease in a surgical GI function laboratory. Dis Esophagus. 1995;8:211–7.
Vakil N, van Zanten SV, Kahrilas PJ, Dent J, Jones R, The Global Consensus Group. The Montreal definition and classification of GERD: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.
Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, SAGES Guideline Committee. Guidelines for surgical treatment of GERD. Surg Endosc. 2010;24(11):2647–69.
Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath OP, Kardos P, Pointner R, Savarino E, Van Herwarden-Lindeboom M, Zaninotto G. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753–73.
Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Romàn J, Walan A, Long-Term Study Group. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118(4):661–9.
Galmiche J-P, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Langstrom G, Lind T, Lundell L. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305:1969–77.
Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K, Willich SN. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care – the ProGERD study. Aliment Pharmacol Ther. 2012;35(1):154–64.
Leodolter A, Nocon M, Vieth M, Lind T, Jaspersen D, Richter K, Willich S, Stolte M, Malfertheiner P, Labenz J. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett’s esophagus: an entity of concern in the ProGERD study. Scand J Gastroenterol. 2012;47(12):1429–35. https://doi.org/10.3109/00365521.2012.733952.
Dallemagne B, Weertz J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C. Clinical results of laparoscopic fundoplication ten years after surgery. Surg Endosc. 2006;20:159–65.
Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, Bremner CG. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication. Ann Surg. 1998;228(1):40–50.
Kamolz T, Granderath F, Pointner R. Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett’s esophagus. Surg Endosc. 2003;17:880–5.
Patti MG, Robinson T, Galvani C, Gorodner MV, Fisichella PM, Way LW. Total fundoplication is superior to partial fundoplication even when esophageal peristalsis is weak. J Am Coll Surg. 2004;198:863–9.
Fuchs KH, Breithaupt W, Fein M, Maroske J, Hammer I. Laparoscopic Nissen repair: indications, techniques and long term benefits. Langenbecks Arch Surg. 2005;390:197–202.
Metha S, Bennett J, Mahon D, Rhodes M. Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy für gastroesophageal reflux disease: seven-year follow up. J Gastrointest Surg. 2006;10(9):1312–7.
Anvari M, Allen C, Marshall J, Armstrong D, Goree R, Ungar W, Goldsmith C. A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastrooesophageal reflux disease (GERD): 3 year outcomes. Surg Endosc. 2011;25(8):2547–54.
Faria R, Bojke L, Epstein D, Corbacho B, Sculpher M, REFLUX Trial Group. Cost effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of GERD based on long-term follow-up of the REFLUX trial. Br J Surg. 2013;100:1205–13.
Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-esophageal reflux disease. Lancet. 1990;335:205–8.
Costantini M, Crookes PF, Bremner RM, Hoeft SF, Ehsan A, Peters JH, Bremner CG, DeMeester TR. Value of physiologic assessment of foregut symptoms in a surgical practice. Surgery. 1993;114(4):780–6.
Bradley LA, Richter JE, Pulliam TJ, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol. 1993;88(1):11–9.
Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux functional dyspepsia and its association with symptom profile. Gut. 2005;54(10):1370–6.
Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, Vigneri S, Camerini G, Tutuian R, Savarino V. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58(9):1185–91.
Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107:1826–32.
Fuchs KH, Musial F, Ulbricht F, Breithaupt W, Reinisch A, Schulz T, Babic B, Fuchs HF, Varga G. Foregut symptoms, somatoform tendencies, and the selection of patients for antireflux surgery. Dis Esophagus. 2017;30:1–10.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.
Zerbib F, Roman S, Ropert A, des Varannes SB, Pouderoux P, Chaput U, Mion F, Vérin E, Galmiche JP, Sifrim D. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101(9):1956–63.
Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105:1053–61.
Lord RVN, DeMeester SR, Peters JH, Hagen JA, Elyssnia D, Sheth CT, DeMeester TR. Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg. 2009;13:602–10.
Fein M, Ritter M, DeMeester TR, Oberg S, Peters JH, Hagen JA, Bremner CG. Role of lower esophageal sphincter and hiatal hernia in the pathogenesis of GERD. J Gastrointest Surg. 1999;3(4):405–10.
Mattioli S, Lugaresi ML, Costantini M, Del Genio A, Di Martino N, Fei L, Fumagalli U, Maffettone V, Monaco L, Morino M, Rebecchi F, Rosati R, Rossi M, Sant S, Trapani V, Zaninotto G. The short esophagus: intraoperative assessment of esophageal length. J Thorac Cardiovasc Surg. 2008;136:1610.
Wayman J, Myers JC, Jamieson GG. Preoperative gastric emptying and patterns of reflux as predictors of outcome after laparoscopic fundoplication. Br J Surg. 2007;94(5):592–8.
Chan WW, Haroian LR, Gyawali CP. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc. 2011;25:2943–9.
Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE. Side effects of long-term proton pump inhibitor use: a review. Basic Clin Pharmacol Toxicol. 2018;123(2):114–21. https://doi.org/10.1111/bcpt.13023.
Rantanen TK, Salo JA. GERD as a cause of death: analysis of fatal cases under conservative therapy. Scand J Gastroenterol. 1999;34(3):229–33.
Labenz J, Chandrasoma PT, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc. 2018;10(9):175–83. https://doi.org/10.4253/wjge.v10.i9.175.
Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J. Risk of esophageal adenocarcinoma after antireflux surgery in patients with gastroesophageal reflux disease in the Nordic countries. JAMA Oncol. 2018;4(11):1576–82. https://doi.org/10.1001/jamaoncol.2018.3054.
DeMeester TR, Bonavina L, Abertucci M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg. 1986;204:19.
Fein M, Bueter M, Thalheimer A, Pachmayer V, Heimbucher J, Freys SM, Fuchs KH. Ten year outcome of laparoscopic antireflux procedures. J Gastrointest Surg. 2008;12:1893–9.
Brehant O, Pessaux P, Arnaud JP, Delattre JF, Meyer C, Baulieux J, Mosnier H. Long-term outcome of laparoscopic antireflux surgery in the elderly. J Gastrointest Surg. 2006;10(3):439–44.
Grotenhuis BA, Wijnhoven BP, Bessell JR, Watson DI. Laparoscopic antireflux surgery in the elderly. Surg Endosc. 2008;22(8):1807–12.
Broeders JA, Draaisma WA, Bredenoord AJ, Smout AJ, Broeders IA, Gooszen HG. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-oesophageal reflux disease. Br J Surg. 2010;97:845–52.
Kaufmann JA, Houghland JE, Quiroga E, Cahill M, Pellegrini CA, Oelschlager BK. Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc. 2006;20:1824–30.
Catania RA, Kavic Stephen M, Roth S, Lee TH, Meyer T, Fantry GT, Castellanos PF, Park A. Laparoscopic Nissen fundoplication effectively relieves symptoms in patient with laryngopharyngeal reflux. J Gastrointest Surg. 2007;11:1579–88.
Salminen P, Sala E, Koskenvuo J, Karvonen J, Ovaska J. Reflux laryngitis: a feasible indication for laparoscopic antireflux surgery. Surg Laparosc Endosc Percutan Tech. 2007;17:73–8.
Barry DW, Vaezi MF. Laryngopharyngeal reflux: more questions than answers. Cleve Clin J Med. 2010;77:337–4.
Wilhelm D, Jell A, Feussner H, Schmid RM, Bajbouj M, Becker V. Pharyngeal pH monitoring in gastrectomy patients – what do we really measure? United European Gastroenterol J. 2016;4(4):541–5. https://doi.org/10.1177/2050640615617637.
Nennstiel S, Andrea M, Abdelhafez M, Haller B, Schmid RM, Bajbouj M, Becker V. pH/multichannel impedance monitoring in patients with laryngo-pharyngeal reflux symptoms – prediction of therapy response in long-term follow-up. Arab J Gastroenterol. 2016;17(3):113–6. https://doi.org/10.1016/j.ajg.2016.08.007.
Fuchs HF, Muller DT, Berlth F, et al. Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux disease. Dis Esophagus. 2018;31(10) https://doi.org/10.1093/dote/doy018.
Tack J, Van den Houte K, Carbone F. Gastroduodenal motility disorders. Curr Opin Gastroenterol. 2018;34(6):428–35. https://doi.org/10.1097/MOG.0000000000000473.
Zehetner J, Ravari F, Ayazi S, Skibba A, Iarehzereshki A, Pelipad D, Mason RJ, Katkhouda N, Lipham JC. Minimally invasive surgical approach for the treatment of gastroparesis. Surg Endosc. 2013;27:61–6.
Maddern GJ, Jamieson GG. Fundoplication enhances gastric emptying. Ann Surg. 1985;201:296–9.
Khajanchee YS, Dunst CM, Swanström LL. Outcomes of Nissen fundoplication in patients with gastroesophageal reflux disease and delayed gastric emptying. Arch Surg. 2009;144(9):823–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fuchs, H.F. (2020). Indications for Interventional and Surgical Therapy in GERD. In: Horgan, S., Fuchs, KH. (eds) Management of Gastroesophageal Reflux Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-48009-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-48009-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-48008-0
Online ISBN: 978-3-030-48009-7
eBook Packages: MedicineMedicine (R0)